1887
Preview this article:

There is no abstract available.

Keyword(s): biology , LDV , pathogenesis and replication
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-66-11-2297
1985-11-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/66/11/JV0660112297.html?itemId=/content/journal/jgv/10.1099/0022-1317-66-11-2297&mimeType=html&fmt=ahah

References

  1. Allison A. C., Harington J. S., Birbeck M. 1966; An examination of the cytotoxic effects of silica on macrophages. Journal of Experimental Medicine 124:141–154
    [Google Scholar]
  2. Almeida J. D., Mims C. A. 1974; The unique morphology of the lactic dehydrogenase agent. Microbios 10:175–180
    [Google Scholar]
  3. Appella E., Markert C. L. 1961; Dissociation of lactate dehydrogenase into subunits with guanidine hydrochloride. Biochemical and Biophysical Research Communications 6:171–176
    [Google Scholar]
  4. Bendinelli M., Asherson G. L. 1971; Depression of contact sensitivity by Friend and Riley viruses. Bollettino dellIstituto sieroterapico milanese 50:502–507
    [Google Scholar]
  5. Bentley D. M., Morris R. E. 1982; T cell subsets required for protection against age-dependent polio-encephalomyelitis of C58 mice. Journal of Immunology 128:530–534
    [Google Scholar]
  6. Bentley D. M., Guckian V. A., Stinnett J. D., Morris R. E. 1982; Failure to demonstrate a role for line Ib tumor associated surface antigen in the etiology of ADPE. Molecular Immunology 19:983–989
    [Google Scholar]
  7. Bentley D. M., Watson S. R., Morris R. E. 1983; Age related loss of Lyt 1, 2 cells in C58 mice results in susceptibility to lactic dehydrogenase virus-induced polioencephalomyelitis. Infection and Immunity 41:1389–1390
    [Google Scholar]
  8. Bonventre P. F., Bubel H. C., Michael J. G., Nickol A. D. 1980; Impaired resistance to bacterial infection after tumor implant is traced to lactic dehydrogenase virus. Infection and Immunity 30:316–319
    [Google Scholar]
  9. Bracha M., Sagher D., Brown A., Schlesinger M. J. 1977; The protease inhibitor p-nitrophenyl-p-guanidinobenzoate inactivates Sindbis and other enveloped viruses. Virology 77:45–55
    [Google Scholar]
  10. Brinton M. A. 1980a; Genetically-controlled resistance to togaviruses. In Gene Control of Natural Resistance to Infection and Malignancy pp 297–303 Edited by Skjamene E., Kongshavn P. A. L., Landy M. London: Academic Press;
    [Google Scholar]
  11. Brinton M. A. 1980b; Lactate dehydrogenase virus (LDV) induced polioencephalitis of C58 mice. In Search for the Cause of Multiple Sclerosis and Other Chronic Diseases of the Central Nervous System pp 222–229 Edited by Boese A. Weinheim: Chemie;
    [Google Scholar]
  12. Brinton M. A. 1980c; Non-arbo togaviruses. Lactate dehydrogenase-elevating virus. In The Togaviruses: Biology Structure, Replication pp 623–666 Edited by Schlesinger R. W. London: Academic Press;
    [Google Scholar]
  13. Brinton M. A. 1981; Genetically controlled resistance to Flavivirus and lactate dehydrogenase-elevating virus-induced disease. Current Topics in Microbiology and Immunology 92:1–14
    [Google Scholar]
  14. Brinton M. A. 1982; Lactate dehydrogenase-elevating virus. In The Mouse in Biomedical Research vol II pp 193–208 Edited by Foster H. L., Small J. D., Fox J. G. London: Academic Press;
    [Google Scholar]
  15. Brinton M. A., Plagemann P. G. W. 1979; Actinomycin D cytotoxicity for mouse peritoneal macrophages and effect on lactate dehydrogenase-elevating virus replication. Intervirology 12:349–356
    [Google Scholar]
  16. Brinton-Darnell M., Brand I. 1977; Delayed foreign body tumorigenesis in mice infected with lactate dehydrogenase-elevating virus: brief communication. Journal of the National Cancer Institute 59:1027–1029
    [Google Scholar]
  17. Brinton-Darnell M., Plagemann P. G. W. 1975; Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. Journal of Virology 16:420–433
    [Google Scholar]
  18. Brinton-Darnell M., Collins J. K., Plagemann P. G. W. 1975; Lactate dehydrogenase-elevating virus replication, maturation and viral RNA synthesis in primary mouse macrophage cultures. Virology 65:187–195
    [Google Scholar]
  19. Cafruny W. A., Plagemann P. G. W. 1982a; Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infection and Immunity 37:1001–1006
    [Google Scholar]
  20. Cafruny W. A., Plagemann P. G. W. 1982b; Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infection and Immunity 37:1007–1012
    [Google Scholar]
  21. Cafruny W. A., Strancke C. R., Kowalchyk K., Plagemann P. G. W. 1986; Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease. Journal of General Virology (in press)
    [Google Scholar]
  22. Cianciolo G. T., Matthews T. J., Bolognesi D. P., Snyderman R. 1980; Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. Journal of Immunology 124:2900–2905
    [Google Scholar]
  23. Coutelier J. P., Van Snick J. 1985; Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. European Journal of Immunology 15:250–255
    [Google Scholar]
  24. Crispens C. G. 1967; Lactate dehydrogenase virus and mouse embryos. Nature London 214:819
    [Google Scholar]
  25. Crispens C. G. 1969; Additional studies on the effect of the lactate dehydrogenase virus on murine sex ratios. Experientia 25:1197–1198
    [Google Scholar]
  26. Crispens C. G. 1982; Detection and characterization of a lymphocyte proliferating factor (LPF) in plasma of SJL/J mice infected with LDH virus. Archives of Virology 72:67–74
    [Google Scholar]
  27. De Thé G., Notkins A. L. 1965; Ultrastructure of the lactic dehydrogenase virus (LDV) and cell-virus relationship. Virology 26:512–516
    [Google Scholar]
  28. Dolowy W. C., Riley V., Spackman D. H. 1974; Antitumor effect of L-asparaginase against the Gardner lymphosarcoma with and without the LDH-virus. Cancer Biochemistry and Biophysics 1:53–55
    [Google Scholar]
  29. Du Buy H. 1975; Effect of silica on virus infections in mice and mouse tissue culture. Infection and Immunity 11:996–1002
    [Google Scholar]
  30. Du Buy H., Baron S., Ohlendorf C., Iohnson M. L. 1973; Role of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro . Infection and Immunity 8:977–984
    [Google Scholar]
  31. Duffey P. S., Lukasewycz D. A., Martinez D., Murphy W. H. 1976a; Pathogenic mechanisms in immune polioencephalomyelitis: quantitative evaluation of protective and pathogenetic effect of lymphoid cells. Journal of Immunology 116:1332–1336
    [Google Scholar]
  32. Duffey P. S., Martinez D., Abrams G. D., Murphy W. H. 1976b; Pathogenic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice. Journal of Immunology 116:475–481
    [Google Scholar]
  33. Georgii A., Lenz I., Zobel H. 1964; Penetration of the placental barrier by the lactate dehydrogenase-elevating virus (Riley) and its behaviour in mouse embryo cultures following infection in utero . Proceedings of the Society for Experimental Biology and Medicine 117:322–326
    [Google Scholar]
  34. Henderson D. C., Tosta C. E., Wedderburn N. 1978; Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus. Clinical and Experimental Immunology 33:357–359
    [Google Scholar]
  35. Henderson D. C., Chang R. W. S., Turk J. L. 1979; Infection with LDH virus alters host response to tumours. British Journal of Cancer 39:453–456
    [Google Scholar]
  36. Hollander N., Isakov N., Segal S., Feldman M. 1978; An immunoregulatory factor associated with spleen cells from tumor-bearing animals. II. Characterization of the cell populations involved in its production and release. International Journal of Cancer 22:471–478
    [Google Scholar]
  37. Homburger H., Abrams G. D., Lawton J. W. M., Murphy W. H. 1973; Histopathology of serum-transmitted immune polioencephalomyelitis in C58 mice. Proceedings of the Society for Experimental Biology and Medicine 144:979–982
    [Google Scholar]
  38. Horzinek M. C., Van Wielink P. S., Ellens D. J. 1975; Purification and electron microscopy of lactic dehydrogenase virus of mice. Journal of General Virology 26:217–226
    [Google Scholar]
  39. Howard R. J., Notkins A. L., Mergenhagen S. E. 1969; Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature, London 221:873–874
    [Google Scholar]
  40. Inada T., Mims C. A. 1984; Mouse la antigens are receptors for lactate dehydrogenase virus. Nature, London 309:59–61
    [Google Scholar]
  41. Inada T., Mims C. A. 1985; Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. Journal of General Virology 66:1469–1477
    [Google Scholar]
  42. Iorio A. M., Barzi A., Merletti P. R., Goldin A., Bonmassar E. 1976; A viral immunodepressive factor associated with experimental mouse tumors. Cancer Research 36:3851–3853
    [Google Scholar]
  43. Isakov N., Segal S. 1982; Modulation of the splenic antibody response following infection of mice with lactic dehydrogenase virus. Immunology 163:228–229
    [Google Scholar]
  44. Isakov N., Segal S. 1983; A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes . Immunobiology 164:402–416
    [Google Scholar]
  45. Isakov N., Segal S., Hollander N., Feldman M. 1978; An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect of tumor growth and antibody production. International Journal of Cancer 22:465–470
    [Google Scholar]
  46. Isakov N., Feldman M., Segal S. 1980; Effect of infection with lactic dehydrogenase virus on the humoral immune response. Israel Journal of Medical Sciences 16:810
    [Google Scholar]
  47. Isakov N., Feldman M., Segal S. 1981a; Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth. Cancer Research 41:667–672
    [Google Scholar]
  48. Isakov N., Segal S., Feldman M. 1981b; The immunoregulatory characteristics of the lactic dehydrogenase virus (LDV), a common contaminant of tumors. Cellular and Molecular Biology 27:83–96
    [Google Scholar]
  49. Isakov N., Feldman M., Segal S. 1982a; The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus. Journal of Immunology 128:969–975
    [Google Scholar]
  50. Isakov N., Feldman M., Segal S. 1982b; Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Immunobiology 162:15–27
    [Google Scholar]
  51. Isakov N., Feldman M., Segal S. 1982c; Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cellular Immunology 66:317–332
    [Google Scholar]
  52. Jaenicke R., Knof S. 1968; Molecular weight and quaternary structure of lactic dehydrogenase. 3. Comparative determination by sedimentation analysis, light scattering and osmosis. European Journal of Biochemistry 4:157–163
    [Google Scholar]
  53. Johnson M. L., Du Buy H. G. 1975; Effect of a potent interferon inducer on acute and chronic lactic dehydrogenase virus viremia. Infection and Immunity 11:113–116
    [Google Scholar]
  54. Johnson R. J., Shin H. K. 1983; Lack of correlation of growth attenuation of murine lymphoma caused by in vitro passage with loss of lactate dehydrogenase virus. Journal of the National Cancer Institute 71:1337–1341
    [Google Scholar]
  55. Kamo L., Patel C., Friedman H. 1976; Altered immunologic responsiveness in mastocytoma-bearing mice. Journal of the National Cancer Institute 56:333–338
    [Google Scholar]
  56. Kascsak R. J., Carp R. I., Donnenfeld H., Bartfeld H. 1983; Kinetics of replication of lactate dehydrogenase-elevating virus in age-dependent polioencephalomyelitis. Intervirology 19:6–15
    [Google Scholar]
  57. Kowalchyk K., Plagemann P. G. W. 1985; Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulations of macrophages. Virus Research 2:211–229
    [Google Scholar]
  58. Lagwinska E., Stewart C. C., Adles C., Schlesinger S. 1975; Replication of lactic dehydrogenase virus and Sindbis virus in mouse peritoneal macrophages. Induction of Interferon and phenotypic mixing. Virology 65:204–214
    [Google Scholar]
  59. Lawton J. W. M., Murphy W. H. 1973; Histopathology of immune polioencephalomyelitis in C58 mice. Archives of Neurology 28:367–370
    [Google Scholar]
  60. Lussenhop N., Holmes B., Cafruny W. A., Plagemann P. G. W. 1982; Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages. Journal of General Virology 61:25–32
    [Google Scholar]
  61. Mcdonald T. L. 1982; Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV) infected mice. Immunology 45:365–370
    [Google Scholar]
  62. Mcdonald T. L. 1983; Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. Journal of the National Cancer Institute 70:493–497
    [Google Scholar]
  63. Mcdonald T. L., Donnelly T., Weber A., Quenette L. 1983; Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus. Immunology 48:511–517
    [Google Scholar]
  64. Mahy B. W. J., Rowson K. E. K., Salaman M. H., Parr C. W. 1964; Plasma enzyme levels in virus infected mice. Virology 23:528–541
    [Google Scholar]
  65. Marshall J. T. 1977; Synopsis of Asian species of Mus (Rodentia, muridae). Bulletin of the American Museum of Natural History 158:175–220
    [Google Scholar]
  66. Martinez D., Wolanski B., Tytell A. A., Devlin R. G. 1979; Viral etiology of age-dependent polioencephalomyelitis in C58 mice. Infection and Immunity 23:133–139
    [Google Scholar]
  67. Martinez D., Brinton M. A., Tachovsky T. G., Phelps A. H. 1980; Identification of lactate dehydrogenase-elevating virus as the etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice. Infection and Immunity 27:979–987
    [Google Scholar]
  68. Michaelides M. C., Schlesinger S. 1974; Effect of acute or chronic infection with lactic dehydrogenase virus (LDV) on the susceptibility of mice to plasmacytoma MOPC–315. Journal of Immunology 112:1560–1564
    [Google Scholar]
  69. Michaelides M. C., Simms E. S. 1977a; Immune response in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Immunology 32:981–988
    [Google Scholar]
  70. Michaelides M. C., Simms E. S. 1977b; Immune response in mice infected with lactic dehydrogenase virus. II. Contact sensitization to DNFB and characterization of lymphoid cells during acute LDV infection. Cellular Immunology 29:285–294
    [Google Scholar]
  71. Michaelides M. C., Simms E. S. 1979; Immune response in mice infected with lactic dehydrogenase virus. IV,. Functional states of the macrophage during acute LDV infection. Immunology 36:241–246
    [Google Scholar]
  72. Michaelides M. C., Simms E. S. 1980; Immune response in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cellular Immunology 50:253–260
    [Google Scholar]
  73. Mongini P. K. A., Rosenberg L. T. 1976; Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition. Journal of Experimental Medicine 143:100–113
    [Google Scholar]
  74. Mongini P. K. A., Rosenberg L. T. 1978; Lactic dehydrogenase virus alteration of lymphocyte circulation. Journal of Immunology 120:459–462
    [Google Scholar]
  75. Morris R. E., Murphy W. H. 1978; Immunogenicity and paralytogenicity of antigens solubilized from line lb malignant lymphocytes. Proceedings of the Society for Experimental Biology and Medicine 157:330–335
    [Google Scholar]
  76. Motyčka K., Jandová A., Krivakova M., Coupek J., Pezlarova J. 1976a; Gel chromatography of serum from mice infected with a virus elevating L-lactate:NAD oxidoreductase activity - an attempt to separate viral and enzymatic activities. Acta virologica 20:53–60
    [Google Scholar]
  77. Motyčka K., Jandová A., Pezlarova J. 1976b; A study of LDH virus infection transfer from parents to offspring. Shornik lekarsky 78:176–180
    [Google Scholar]
  78. Motyčka K., Bostik J., Slavik K., Bures L., Pezlarova J., Jandova A. 1984a; LDH-viral activity transferred with cell surface antigens of Gardner lymphosarcoma cells. Zeitschrift fur die Versuchstierkunde 26:209–210
    [Google Scholar]
  79. Motyčka K., Herzon P., Chudomel V., Bostik J., Jandová A., Pezlarova J., Stepanova I. 1984b; Effect of alexan® on the number of plaque forming cells collected from spleens of mice strain C3H with Gardner’s lymphosarcoma or infected with LDH virus. Sbornik lékařský 86:251–258
    [Google Scholar]
  80. Murphy F. A. 1980; Lactic dehydrogenase virus. In The Togaviruses: Biology Structure, Replication pp 302–304 Edited by Schlesinger R. W. London: Academic Press;
    [Google Scholar]
  81. Murphy W. H. 1979; Mouse model for motor neurone disease - immune polioencephalomyelitis. In Progress in Neurological Research pp 175–193 Edited by Behan P. O., Rose F. C. London: Pitman Medical;
    [Google Scholar]
  82. Murphy W. H., Tam M. R., Lanzi R. L., Abell M. R., Kauffman C. 1970; Age dependence of immunologically induced central nervous system disease in C58 mice. Cancer Research 30:1612–1622
    [Google Scholar]
  83. Murphy W. H., Nawrocki J. F., Pease L. R. 1980; Etiologic mechanisms in age-dependent motor neurone disease. In Animal Models of Neurologic Disease pp 123–135 Edited by Rose C. F., Behan P. O. London: Pitman Medical;
    [Google Scholar]
  84. Murphy W. H., Nawrocki J. F., Pease L. R. 1983; Age-dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease. Progress in Brain Research 59:291–303
    [Google Scholar]
  85. Nawrocki J. F., Pease L. R., Murphy W. H. 1980; Etiologic role of lactic dehydrogenase virus infection in an age-dependent neuroparalytic disease in C58 mice. Virology 103:259–264
    [Google Scholar]
  86. Notkins A. L. 1965; Lactic dehydrogenase virus. Bacteriological Reviews 29:143–160
    [Google Scholar]
  87. Notkins A. L., Scheele C. 1963; Studies on the transmission and the extraction of the lactic dehydrogenase agent. Journal of Experimental Medicine 118:7–12
    [Google Scholar]
  88. Notkins A. L., Mahar S., Scheele C., Goffman J. 1966; Infectious virus-antibody complex in the blood of chronically infected mice. Journal of Experimental Medicine 124:81–97
    [Google Scholar]
  89. Notkins A. L., Mage M., Ashe W. K., Mahar S. 1968; Neutralization of sensitized lactic dehydrogenase virus by anti-tx-globulin. Journal of Immunology 100:314–320
    [Google Scholar]
  90. Oldham G., Poole A. R., Brownson J. M., Mahy B. W. J., Coombs R. R. A. 1980; Experiments in mice and rats on the induction of joint lesions following injections of serum and in chronic virus infection. International Archives of Allergy and Applied Immunology 62:213–220
    [Google Scholar]
  91. Oldstone M. B. A., Dixon F. J. 1971; Lactic dehydrogenase virus-induced immune complex type of glomerulonephritis. Journal of Immunology 106:1260–1263
    [Google Scholar]
  92. Oldstone M. B. A., Dixon F. J. 1972; Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science 175:784–786
    [Google Scholar]
  93. Oldstone M. B. A., Tishon A., Chiller J. M. 1974; Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens. Journal of Immunology 112:370–375
    [Google Scholar]
  94. Pease L. R., Murphy W. H. 1980; Co-infection by lactic dehydrogenase virus and C-type retrovirus elicits neurological disease. Nature, London 286:398–400
    [Google Scholar]
  95. Pease L. R., Abrams G. D., Murphy W. H. 1982; Fv-1 restriction of age-dependent paralytic lactic dehydrogenase virus infection. Virology 117:29–37
    [Google Scholar]
  96. Pope J. H. 1961; Studies of a virus isolated from a wild house mouse, Mus musculus, and producing splenomegaly and lymph node enlargement in mice. Australian Journal of Experimental Biology and Medical Science 39:521–536
    [Google Scholar]
  97. Porter D. D., Porter H. G. 1971; Deposition of immune complexes in the kidneys of mice infected with lactic dehydrogenase virus. Journal of Immunology 106:1264–1266
    [Google Scholar]
  98. Porter D. D., Porter H. G., Deerhake B. B. 1969; Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. Journal of Immunology 102:431–436
    [Google Scholar]
  99. Proffitt M. R., Congdon C. C., Tyndall R. L. 1972; The combined action of Rauscher leukemia virus and lactic dehydrogenase virus on mouse lymphatic tissue. International Journal of Cancer 9:193–211
    [Google Scholar]
  100. Prosser P. R., Evans R. 1967; An electron microscopic study of lactic dehydrogenase virus in cultures of mouse peritoneal macrophages. Journal of General Virology 1:419–424
    [Google Scholar]
  101. Riley V. 1968; Lactate dehydrogenase in the normal and malignant state in mice and the influence of a benign enzyme-elevating virus. In Methods in Cancer Research vol 4: pp 493–618 Edited by Busch H. London: Academic Press;
    [Google Scholar]
  102. Riley V., Spackman D. 1974; Modifying effects of a benign virus on the malignant process and the role of physiological stress on tumor incidence. Fogerty International Center Proceedings 28:319–336
    [Google Scholar]
  103. Riley V., Spaceman D. 1976; Melanoma enhancement by viral induced stress. In Pigment Cell vol 2: pp 163–173 Edited by Riley V. Basel: S. Karger;
    [Google Scholar]
  104. Riley V., Lilly F., Huerto E., Bardell D. 1960; Transmissible agent associated with 26 types of experimental mouse neoplasms. Science 132:545–547
    [Google Scholar]
  105. Riley V., Braun W., Ishizuea M., Spaceman D. 1976; Antibody-producing cells: virus-induced alterations of response to antigen. Proceedings of the National Academy of Sciences, U. S. A 73:1707–1711
    [Google Scholar]
  106. Riley V., Spaceman D. H., Santisteban G. A., Dalldorf G., Hellstrom I., Hellstrom E. E., Lance E. M., Rowson E. E. E., Mahy B. W. J., Alexander P., Stoce C. C., Sjogren H. D., Hollander V. P., Horzinee M. C. 1978; The LDH virus: an interfering biological contaminant. Science 200:124–126
    [Google Scholar]
  107. Rowe W. P., Hartley J. W., Hubner R. J. 1962; Polyoma and other indigenous mouse viruses. In The Problems of Laboratory Animal Disease pp 131–142 Edited by Harris R. J. C. London: Academic Press;
    [Google Scholar]
  108. Rowson E. E. E. 1980; A new host species for lactic dehydrogenase virus. Experientia 36:1066
    [Google Scholar]
  109. Rowson E. E. E., Mahy B. W. J. 1975; Lactic dehydrogenase virus. Virology Monographs vol 13: pp 1–121 Vienna & New York: Springer-Verlag;
    [Google Scholar]
  110. Rowson E. E. E., Mahy B. W. J., Bendinelli M. 1966; Riley virus neutralizing activity in the plasma of infected mice with persistent viraemia. Virology 28:775–778
    [Google Scholar]
  111. Sanger M. A., Lawton J. W. M., Murphy W. H. 1973; Serum transmissibiiity of immune poiioencephaiomyelitis in C58 mice. Journal of Immunology 110:219–226
    [Google Scholar]
  112. Santisteban G. A., Riley V., Fitzmaurice M. A. 1972; Thymolytic and adrenal cortical responses to the LDH-elevating virus. Proceedings of the Society for Experimental Biology and Medicine 139:202–206
    [Google Scholar]
  113. Schlesinger S., Lagwinsea E., Stewart C. C., Croce C. M. 1976; Lactic dehydrogenase virus replicates in somatic cell hybrids of mouse peritoneal macrophages and SV 40-transformed human fibroblasts. Virology 74:535–539
    [Google Scholar]
  114. Sinclair N. R. St. C. 1978; Immunoregulation by antibody and antigen-antibody complexes. Transplantation Proceedings 10:349–353
    [Google Scholar]
  115. Snodgrass M. J., Lowrey D. S., Hanna M. G. 1972; Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. Journal of Immunology 108:877–892
    [Google Scholar]
  116. Stauber E., Burger D., Piper R. 1975; The pathogenesis of lactate dehydrogenase elevating virus in mice. Journal of Comparative Pathology 85:171–183
    [Google Scholar]
  117. Stevenson M. M., Rees J. C., Meltzer M. S. 1980; Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes. Journal of Immunology 124:2892–2899
    [Google Scholar]
  118. Stroop W. G. 1984; Spinal leptomeningeal epidermoid cysts in inbred mouse strains. Acta neuropathologica 63:301–305
    [Google Scholar]
  119. Stroop W. G., Baringer J. R. 1982; Persistent, slow and latent viral infections. Progress in Medical Virology 28:1–43
    [Google Scholar]
  120. Stroop W. G., Brinton M. A. 1983; Mouse strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection. Laboratory Investigation 49:334–345
    [Google Scholar]
  121. Stroop W. G., Weibel J., Schaefer D., Brinton M. A. 1985; Ultrastructural and immunofluorescent studies of acute and chronic lactate dehydrogenase elevating virus-induced non-paralytic poliomyelitis in mice. Proceedings of the Society for Experimental Biology and Medicine 178:261–274
    [Google Scholar]
  122. Stueckemann J. A., Holth M., Swart W. J., Kowalchyk K., Smith M. S., Wolstenholme A. J., Cafruny W. A., Plagemann P. G. W. 1982a; Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. Journal of General Virology 59:263–272
    [Google Scholar]
  123. Stueckemann J. A., Ritzi D. M., Holth M., Smith M. S., Swart W. J., Cafruny W. A., Plagemann P. G. W. 1982b; Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. Journal of General Virology 59:245–262
    [Google Scholar]
  124. Theiss J. C., Shimkin M. B., Stoner G. D., Kniazeff A. J., Hoppenstand R. D. 1980; Effect of lactate dehydrogenase virus on chemically induced Shimkinmstonerg Kniazeff, A Effect of mouse lung tumorigenesis. Cancer Research 40:64–66
    [Google Scholar]
  125. Tong S. L., Stueckemann J. A., Plagemann P. G. W. 1977; Autoradiographic method for detection of lactate dehydrogenase-elevating virus-infected cells in primary mouse macrophage cultures. Journal of Virology 22:219–227
    [Google Scholar]
  126. Treves A. J., Cohen I. R., Feldman M. 1976; Suppressor factor secreted by T-lymphocytes from tumor-bearing mice. Journal of the National Cancer Institute 57:409–414
    [Google Scholar]
  127. Turk J. L., Parker D. 1982; Effect of cyclophosphamide on immunological control mechanisms. Immunological Review 65:99–113
    [Google Scholar]
  128. Vincent M. D., Potter J. G., Cooper S. 1977; Immunodepression, ascites tumour and lactate dehydrogenase virus. South African Medical Journal 52:924–926
    [Google Scholar]
  129. Virolainen M., Defendi C. 1967; Dependence of macrophage growth in vitro upon interaction with other cell types. In Growth Regulating Substances for Animal Cells in Culture pp 67–85 Edited by Defendi V., Stoker M. Philadelphia: Wistar Institute Symposium Monographs, no. 7;
    [Google Scholar]
  130. Voisin G. A. 1980; Role of antibody classes in the regulatory facilitation reaction. Immunological Review 49:3–59
    [Google Scholar]
  131. Wachsmuth E. D., Klingmuller D. 1978; Reduction of plasma clearance rates and immune response by negative charges: lactic dehydrogenase isoenzymes in normal and LDV-infected mice. Journal of the Reticuloendothelial Society 24:227–241
    [Google Scholar]
  132. Yaffe D. 1962; The distribution and in vitro propagation of an agent causing high plasma lactic dehydrogenase activity. Cancer Research 22:573–580
    [Google Scholar]
  133. Yamazaki S., Notkins A. L. 1973; Inhibition of replication of lactic dehydrogenase virus by actinomycin. Journal of Virology 11:473–478
    [Google Scholar]
  134. Zeegers J. J. W., Van Der Zeijst B. A. M., Horzinek M. C. 1976; The structural proteins of equine arteritis virus. Virology 73:200–205
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-66-11-2297
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error